Protein misfolding and medicinal strategies in neurodegenerative disorders

被引:0
|
作者
Mehboudi, Leila [1 ]
Zahedirad, Mehrshad [2 ]
Vadiei, Parisa [2 ]
机构
[1] Jahrom Univ Med Sci, Fac Med, Dept Anesthesia, Jahrom, Iran
[2] Islamic Azad Univ, Dept Med Lab, Chalus Branch, Fac Paramed Sci, Chalus, Iran
来源
MEDICINA BALEAR | 2022年 / 37卷 / 04期
关键词
Protein misfolding; Alzheimer's disease; Huntington's disease; Parkinson's disease; THERAPEUTIC STRATEGIES; DISEASES;
D O I
10.3306/AJHS.2022.37.04.166
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Proteins that misfold may accumulate and cause disorders like Alzheimer's and Parkinson's. New medicines are also explored to forecast and even cure these illnesses' severe symptoms. Because they were misfolded during creation or maintenance, rogue proteins may harm a biological system. This causes over twenty human illnesses, including Alzheimer's, Huntington's, Parkinson's, and other neurodegenerative diseases. To create new therapies and medications, researchers will need to understand protein misfolding and aggregation formation. To summarize, protein misfolding causes aggregation and neurodegeneration. This suggests that nature employs protein aggregation to execute unique physiological activities in various biological conditions.
引用
收藏
页码:166 / 170
页数:5
相关论文
共 50 条
  • [1] Therapeutic strategies for targeting neurodegenerative protein misfolding disorders
    Scannevin, Robert H.
    CURRENT OPINION IN CHEMICAL BIOLOGY, 2018, 44 : 66 - 74
  • [2] Protein folding and misfolding in the neurodegenerative disorders: A review
    Boshette, N. B.
    Thakur, K. K.
    Bidkar, A. P.
    Trandafir, C.
    Kumar, P.
    Gogoi, R.
    REVUE NEUROLOGIQUE, 2014, 170 (03) : 151 - 161
  • [3] Protein misfolding in neurodegenerative diseases: implications and strategies
    Sweeney, Patrick
    Park, Hyunsun
    Baumann, Marc
    Dunlop, John
    Frydman, Judith
    Kopito, Ron
    McCampbell, Alexander
    Leblanc, Gabrielle
    Venkateswaran, Anjli
    Nurmi, Antti
    Hodgson, Robert
    TRANSLATIONAL NEURODEGENERATION, 2017, 6
  • [4] Protein misfolding in neurodegenerative diseases: implications and strategies
    Patrick Sweeney
    Hyunsun Park
    Marc Baumann
    John Dunlop
    Judith Frydman
    Ron Kopito
    Alexander McCampbell
    Gabrielle Leblanc
    Anjli Venkateswaran
    Antti Nurmi
    Robert Hodgson
    Translational Neurodegeneration, 6
  • [5] Therapeutic strategies against protein misfolding in neurodegenerative diseases
    Soto, Claudio
    Martin, Zane
    EXPERT OPINION ON DRUG DISCOVERY, 2009, 4 (01) : 71 - 84
  • [6] Polyphenolic compounds for treating neurodegenerative disorders involving protein misfolding
    Ho, Lap
    Pasinetti, Giulio Maria
    EXPERT REVIEW OF PROTEOMICS, 2010, 7 (04) : 579 - 589
  • [7] Targeting Protein Misfolding and Aggregation as a Therapeutic Perspective in Neurodegenerative Disorders
    Sidoryk-Wegrzynowicz, Marta
    Adamiak, Kamil
    Struzynska, Lidia
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (22)
  • [8] Parkinson's disease and tauopathies: Neurodegenerative protein misfolding disorders
    Trojanowski, JQ
    MOVEMENT DISORDERS, 2006, 21 : S5 - S5
  • [9] Protein misfolding in neurodegenerative diseases
    Agorogiannis, EI
    Agorogiannis, GI
    Papadimitriou, A
    Hadjigeorgiou, GM
    NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY, 2004, 30 (03) : 215 - 224
  • [10] Minocycline as a potential therapeutic agent in neurodegenerative disorders characterised by protein misfolding
    Noble, Wendy
    Garwood, Claire J.
    Hanger, Diane P.
    PRION, 2009, 3 (02) : 78 - 83